seems they timed the capital raising at 33.5c to perfection. Fully funded until investment decision so will be able to ride out the storm without further dilution
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial